Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the completion of a comprehensive hospital-wide analysis of Tampere Heart Hospital - Tampere University Hospital's (Finland) environmental sustainability, including a deep assessment of the interventional cardiology space and evaluation of its carbon footprint. 
Bayer and Hologic, Inc., today announced an international partnership to deliver contrast-enhanced-mammography (CEM) solutions to improve the detection of breast cancer in multiple countries across Canada, the European and Asia Pacific regions.
CEM is an innovative highly sensitive and low-cost breast imaging modality which combines digital mammography with the administration of a contrast agent to support breast cancer diagnosis and guide treatment decisions.
Siemens Healthineers is expanding its site in Rudolstadt, Germany. By mid 2024, a new manufacturing building will be built on the site. The new manufacturing plant will produce electron accelerators that will be used as radiation sources for Varian's cancer therapy devices. Varian has been a Siemens Healthineers company since 2021. 
Leading WiFi provider WiFi SPARK is rebranding its healthcare arm as SPARK Technology Services Limited. The new identity marks the completion of the integration of the former Hospedia bedside unit business and a new vision for the NHS, based on patient engagement and application services. 
The Danish eHealth platform, sundhed.dk, has faced a substantial surge in requests from Danish citizens
and has swiftly expanded its support and effectively adapt to the ongoing changes in queries due to the ongoing changes within the Health Industry. To accommodate these changes, sundhed.dk uses the Chatbot
from SupWiz to solve urgent needs for support and provides a nice citizen experience. 
Opinion Article by Guilherme Carvalho, Sales & Contracts Manager, Sectra.The urgency to get these tools in place, means that many NHS trusts and imaging networks will now be engaged in developing bids, ahead of what is a tight September deadline.
Mahana Therapeutics, a leading provider of prescription digital therapeutics, announced today that the company has entered into a multi-million-dollar distribution and marketing partnership with the Consumer Health division of Bayer to commercialize digital therapeutics. Earlier this year, Bayer announced the launch of a new business unit focused on delivering new digitally enabled precision health products to market.